FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W64490004> ?p ?o ?g. }

• W64490004 endingPage "2059" @default.
• W64490004 startingPage "2048" @default.
• W64490004 abstract "Abstract CD30 ligand (CD30L) is a type-II membrane glycoprotein capable of transducing signals leading to either cell death or proliferation through its specific counterstructure CD30. Although several lines of evidence indicate that CD30L plays a key role as a paracrine- or autocrine-acting surface molecule in the deregulated cytokine cascade of Hodgkin's disease, little is known regarding its distribution and biologic significance in other human hematopoietic malignancies. By analyzing tumor cells from 181 patients with RNA studies and immunostaining by the anti-CD30L monoclonal antibody M80, we were able to show that human hematopoietic malignancies of different lineage and maturation stage display a frequent and broad expression of the ligand. CD30L mRNA and surface protein were detected in 60% of acute myeloid leukemias (AMLs), 54% of B-lineage acute lymphoblastic leukemias (ALLs), and in a consistent fraction (68%) of B-cell lymphoproliferative disorders. In this latter group, hairy cell leukemia and high-grade B-cell non-Hodgkin's lymphoma (B-NHL) expressed a higher surface density of CD30L as compared with B-cell chronic lymphocytic leukemia and low-grade B-NHL. Purified plasmacells from a fraction of multiple myeloma patients also displayed CD30L mRNA and protein. A more restricted expression of CD30L was found in T-cell tumors that was mainly confined to neoplasms with an activated peripheral T-cell phenotype, such as T-cell prolymphocytic leukemia, peripheral T-NHL, and adult T-cell leukemia/lymphoma. In contrast, none of the T-lineage ALLs analyzed expressed the ligand. In AML, a high cellular density of CD30L was detected in French-American-British M3, M4, and M5 phenotypes, which are directly associated with the presence on tumor cells of certain surface structures, including the p55 interleukin-2 receptor α-chain, the αM (CD11b) chain of β2 integrins, and the intercellular adhesion molecule-1 (CD54). Analysis of normal hematopoietic cells evidenced that, in addition to circulating and tonsil B cells, a fraction of bone marrow myeloid precursors, erythroblasts, and subsets of megakaryocytes also express CD30L. Finally, we have shown that native CD30L expressed on primary leukemic cells is functionally active by triggering both mitogenic and antiproliferative signals on CD30+ target cells. As opposed to CD30L, only 10 of 181 primary tumors expressed CD30 mRNA or protein, rendering therefore unlikely a CD30-CD30L autocrine loop in human hematopoietic neoplasms. Taken together, our data indicate that CD30L is widely expressed from early to late stages of human hematopoiesis and suggest a regulatory role for this molecule in the interactions of normal and malignant hematopoietic cells with CD30+ immune effectors and/or microenvironmental accessory cells." @default.
• W64490004 created "2016-06-24" @default.
• W64490004 creator A5006278471 @default.
• W64490004 creator A5008113077 @default.
• W64490004 creator A5013579399 @default.
• W64490004 creator A5018250263 @default.
• W64490004 creator A5019598602 @default.
• W64490004 creator A5024924719 @default.
• W64490004 creator A5025968599 @default.
• W64490004 creator A5033029228 @default.
• W64490004 creator A5034356923 @default.
• W64490004 creator A5050464219 @default.
• W64490004 creator A5060324916 @default.
• W64490004 creator A5073179633 @default.
• W64490004 creator A5086301472 @default.
• W64490004 creator A5086413416 @default.
• W64490004 date "1997-03-15" @default.
• W64490004 modified "2023-10-16" @default.
• W64490004 title "CD30 Ligand Is Frequently Expressed in Human Hematopoietic Malignancies of Myeloid and Lymphoid Origin" @default.
• W64490004 cites W104239263 @default.
• W64490004 cites W105127712 @default.
• W64490004 cites W113537759 @default.
• W64490004 cites W1261941413 @default.
• W64490004 cites W1508958674 @default.
• W64490004 cites W1526820115 @default.
• W64490004 cites W1859538971 @default.
• W64490004 cites W1898357572 @default.
• W64490004 cites W1951860957 @default.
• W64490004 cites W1960257587 @default.
• W64490004 cites W1965824265 @default.
• W64490004 cites W1970483076 @default.
• W64490004 cites W1972922050 @default.
• W64490004 cites W1977996162 @default.
• W64490004 cites W1983072511 @default.
• W64490004 cites W1992401642 @default.
• W64490004 cites W2002507218 @default.
• W64490004 cites W2004313295 @default.
• W64490004 cites W2008055247 @default.
• W64490004 cites W2009214773 @default.
• W64490004 cites W2010275957 @default.
• W64490004 cites W2020169783 @default.
• W64490004 cites W2038253006 @default.
• W64490004 cites W2039707741 @default.
• W64490004 cites W2081518187 @default.
• W64490004 cites W2101862196 @default.
• W64490004 cites W2104868334 @default.
• W64490004 cites W2107040913 @default.
• W64490004 cites W2107202569 @default.
• W64490004 cites W2124829295 @default.
• W64490004 cites W2126827505 @default.
• W64490004 cites W2127772222 @default.
• W64490004 cites W2129345746 @default.
• W64490004 cites W2130305562 @default.
• W64490004 cites W2130988210 @default.
• W64490004 cites W2136422032 @default.
• W64490004 cites W2144816341 @default.
• W64490004 cites W2167663806 @default.
• W64490004 cites W2177231732 @default.
• W64490004 cites W2180005201 @default.
• W64490004 cites W2271897229 @default.
• W64490004 cites W2301968512 @default.
• W64490004 cites W2338368417 @default.
• W64490004 cites W2345906158 @default.
• W64490004 cites W2346836846 @default.
• W64490004 cites W2411246781 @default.
• W64490004 cites W2417094179 @default.
• W64490004 cites W3111360752 @default.
• W64490004 cites W4244311939 @default.
• W64490004 doi "https://doi.org/10.1182/blood.v89.6.2048" @default.
• W64490004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9058727" @default.
• W64490004 hasPublicationYear "1997" @default.
• W64490004 type Work @default.
• W64490004 sameAs 64490004 @default.
• W64490004 citedByCount "112" @default.
• W64490004 countsByYear W644900042012 @default.
• W64490004 countsByYear W644900042013 @default.
• W64490004 countsByYear W644900042014 @default.
• W64490004 countsByYear W644900042015 @default.
• W64490004 countsByYear W644900042016 @default.
• W64490004 countsByYear W644900042017 @default.
• W64490004 countsByYear W644900042018 @default.
• W64490004 countsByYear W644900042019 @default.
• W64490004 countsByYear W644900042020 @default.
• W64490004 countsByYear W644900042021 @default.
• W64490004 countsByYear W644900042022 @default.
• W64490004 countsByYear W644900042023 @default.
• W64490004 crossrefType "journal-article" @default.
• W64490004 hasAuthorship W64490004A5006278471 @default.
• W64490004 hasAuthorship W64490004A5008113077 @default.
• W64490004 hasAuthorship W64490004A5013579399 @default.
• W64490004 hasAuthorship W64490004A5018250263 @default.
• W64490004 hasAuthorship W64490004A5019598602 @default.
• W64490004 hasAuthorship W64490004A5024924719 @default.
• W64490004 hasAuthorship W64490004A5025968599 @default.
• W64490004 hasAuthorship W64490004A5033029228 @default.
• W64490004 hasAuthorship W64490004A5034356923 @default.
• W64490004 hasAuthorship W64490004A5050464219 @default.
• W64490004 hasAuthorship W64490004A5060324916 @default.

• next